http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011039256-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1cd0b734b29bdeba9b909691db61ee0 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-26 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-542 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 |
filingDate | 2009-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_595a2267625b68f28170f3e93af93d9e |
publicationDate | 2011-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2011039256-A1 |
titleOfInvention | Detection method |
abstract | A method for detecting the presence of a diagnostic moiety indicative of exposure to an infectious organism in a biological sample taken from a human or animal, said method comprising; (a) adding to said sample a first fluorescently labelled reagent which binds said diagnostic moiety, and a second fluorescently labelled reagent which either binds said diagnostic moiety in addition to said first fluorescently labelled reagent, or which binds the first fluorescently labelled reagent or a complex comprising the first fluorescently labelled reagent in competition to the said diagnostic moiety, wherein a label on one of the first or second fluorescently labelled reagent acts as a fluorescent energy donor compound and wherein the other of the first or second fluorescently labelled reagent acts as a fluorescent energy acceptor compound which is able to accept fluorescent energy from said donor compound; (b) exciting the fluorescent energy donor compound by illuminating with light of a wavelength which is absorbed by said fluorescent energy donor compound; (c) measuring fluorescent signal emitted by said fluorescent energy acceptor compound as a result of its absorption of the fluorescent energy from the donor compound after a time delay; and (d) relating the results to the presence or absence of diagnostic moiety in said sample. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013183696-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015153366-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11346783-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102721802-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020046196-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9964550-B2 |
priorityDate | 2008-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 199.